Overcome the challenges of PMS2 variant calling with Devyser LynchFAP – our new NGS solution
Devyser LynchFAP is the latest addition to Devyser’s expanding hereditary cancer screening...
Please find the terms and conditions for different countries and regions below.
Country | Legal terms |
---|---|
Austria | Terms and conditions |
Benelux | Terms and conditions |
Germany | Terms and conditions |
Switzerland | Terms and conditions |
United Kingdom | Terms and conditions |
Nordics | Terms and conditions |
North America | Terms and conditions |
Distributor sales | Terms and conditions |
France | Terms and conditions |
News | September 06, 2023
Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding BrazilNews | July 17, 2023
Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvalsNews | June 29, 2023
Devyser launches two new genetic testing solutions for hereditary cancerDevyser LynchFAP is the latest addition to Devyser’s expanding hereditary cancer screening...
Read More
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...
Read More
As a lab manager, you know the importance of streamlining workflows to maximize productivity and...
Read More
Do you know a man who has participated at least once in “Movember”? Every year, thousands of men...
Read More